brain cancer (Cancer)
Information
- Disease name
- brain cancer
- Disease ID
- DOID:1319
- Description
- "A central nervous system cancer that is characterized by the growth of abnormal cells in the tissues of the brain." [url:http\://www.cancer.gov/dictionary?CdrID=387264]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04268979 | Active, not recruiting | N/A | Electronic Social Network Assessment Program (eSNAP) + Caregiver Navigator | February 13, 2020 | July 2025 |
| NCT06168825 | Active, not recruiting | Mind Over Matter for Black and African American Women: A Single Arm Trial Examining Feasibility and Acceptability of a Supportive Intervention | January 17, 2024 | December 31, 2024 | |
| NCT04173104 | Active, not recruiting | PET and MRI Imaging of Brain Tumors Using [18F]PARPi | November 1, 2019 | November 2025 | |
| NCT03465618 | Active, not recruiting | Phase 1 | A First in Human Study Using 89Zr-cRGDY Ultrasmall Silica Particle Tracers for Malignant Brain Tumors | March 7, 2018 | March 2025 |
| NCT02851706 | Active, not recruiting | Natural History of and Specimen Banking for People With Tumors of the Central Nervous System | September 1, 2016 | April 5, 2100 | |
| NCT03630289 | Active, not recruiting | N/A | Surgical Tissue Flap to Bypass the Blood Brain Barrier in GBM | July 27, 2018 | December 31, 2023 |
| NCT02375841 | Active, not recruiting | Coping With Glioblastoma: A Study of Communication Between Physicians, Patients, and Caregivers | February 2015 | February 2025 | |
| NCT04023669 | Active, not recruiting | Phase 1 | Evaluation of LY2606368 Therapy in Combination With Cyclophosphamide or Gemcitabine for Children and Adolescents With Refractory or Recurrent Group 3/Group 4 or SHH Medulloblastoma Brain Tumors | August 8, 2019 | October 2024 |
| NCT04964960 | Active, not recruiting | Phase 2 | Pembro+Chemo in Brain Mets | May 19, 2022 | May 2033 |
| NCT02717962 | Active, not recruiting | Phase 2 | Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Glioblastoma in the Adjuvant or Recurrent Setting | January 20, 2017 | March 30, 2024 |
| NCT03050736 | Active, not recruiting | Phase 2 | Safety Study of VAL-083 and Radiotherapy in Patients With Newly Diagnosed GBM Having Unmethylated MGMT Expression | December 17, 2017 | December 30, 2023 |
| NCT01892397 | Active, not recruiting | N/A | Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic Meningioma | June 2013 | June 2024 |
| NCT03972514 | Active, not recruiting | Observational Trial of the Impact of Radiation Dose in Children With Brain and Skull Base Tumors. | March 8, 2019 | March 2030 | |
| NCT05170087 | Active, not recruiting | Radiomic Analysis for Predicting Treatment Response and Clinical Outcomes in Malignancies | March 2, 2020 | March 2025 | |
| NCT00553748 | Completed | Phase 1 | Phase I, Open Label, Single Center Safety Study of [F-18]FLT | November 2007 | May 2008 |
| NCT00581815 | Completed | Phase 1 | Spectroscopy With Surface Coils and Decoupling | February 1997 | February 2014 |
| NCT00590954 | Completed | Phase 2 | Clinical and Molecular-Metabolic Phase II Trial of Perifosine for Recurrent/Progressive Malignant Gliomas | May 2006 | November 11, 2019 |
| NCT00594633 | Completed | Phase 1 | Adjunctive Donepezil Therapy and Genetic Risk Factors of Cognitive Dysfunction in Brain Tumor Survivors | October 2004 | January 2016 |
| NCT00595322 | Completed | N/A | Bevacizumab in the Radiation Treatment of Recurrent Malignant Glioma | December 2005 | May 2017 |
| NCT00597246 | Completed | N/A | Imaging Brain Tumors With FACBC and Methionine | May 13, 2003 | November 27, 2019 |
| NCT00599703 | Completed | Language Function in Patients With Brain Tumors | May 2005 | March 2009 | |
| NCT00706810 | Completed | Phase 2 | Combination of Hydroxyurea and Verapamil for Refractory Meningiomas | December 2007 | September 2015 |
| NCT00723463 | Completed | Early Phase 1 | Determine if Apparent Diffusion Coefficient (ADC) Values Can Differentiate Tumors From Normal Tissue | June 2006 | July 2016 |
| NCT00747253 | Completed | Phase 1 | Monteris AutoLITT™ FIM Safety Trial for Recurrent/Progressive Brain Tumors | August 2008 | April 2010 |
| NCT00782756 | Completed | Phase 2 | Bevacizumab, Temozolomide and Hypofractionated Radiotherapy for Patients With Newly Diagnosed Malignant Glioma | October 28, 2008 | March 23, 2017 |
| NCT00805376 | Completed | Phase 1 | DNX-2401 (Formerly Known as Delta-24-RGD-4C) for Recurrent Malignant Gliomas | February 2009 | February 2015 |
| NCT00832598 | Completed | N/A | [18F] FACBC and [18F] FLT PET Imaging in Central Nervous System Tumors | January 2009 | March 21, 2017 |
| NCT00001807 | Completed | (1)H-Nuclear Magnetic Resonance Spectroscopic Imaging of the Brain in Patients Who Receive Neurotoxic Therapy | April 16, 1999 | April 18, 2019 | |
| NCT00871923 | Completed | Phase 2 | Tarceva With Whole Brain Radiation Therapy - Brain Mets From Non-Small Cell Lung Cancer | March 26, 2009 | December 4, 2019 |
| NCT00876499 | Completed | Fatigue, Sleep and Cytokines in Primary Brain Tumor (PBT) Patients | January 2009 | December 2013 | |
| NCT00883688 | Completed | Phase 2 | Bevacizumab and Lapatinib in Children With Recurrent or Refractory Ependymoma | July 2009 | April 2015 |
| NCT00928226 | Completed | N/A | Study of Fractionated Stereotactic Radiosurgery to Treat Large Brain Metastases | April 2009 | December 2019 |
| NCT00946673 | Completed | Phase 1 | Phase I Vorinostat Concurrent With Stereotactic Radiosurgery (SRS) in Brain Metastases From Non-Small Cell Lung Cancer | June 2009 | July 2015 |
| NCT00979810 | Completed | N/A | Image-Guided Stereotactic Biopsy of High Grade Gliomas | September 16, 2009 | February 24, 2020 |
| NCT01012609 | Completed | Phase 2 | External Beam Radiation Therapy and Cetuximab Followed by Irinotecan and Cetuximab for Children and Young Adults With Newly Diagnosed Diffuse Pontine Tumors and High-Grade Astrocytomas | October 30, 2009 | January 15, 2018 |
| NCT01017497 | Completed | N/A | Optimal Planning Target Volume With Stereotactic Radiosurgery | December 2009 | December 2013 |
| NCT05131815 | Completed | N/A | The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors | January 10, 2022 | August 21, 2023 |
| NCT01067469 | Completed | Phase 2 | Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM) | January 2010 | October 2016 |
| NCT04704804 | Completed | Feasibility of MRI Workflow Alone in External Radiotherapy for the Treatment of Brain and Prostate Tumors | July 24, 2020 | July 15, 2021 | |
| NCT04430842 | Completed | Phase 1 | Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S | July 20, 2020 | December 22, 2022 |
| NCT01257594 | Completed | Phase 1 | EGFR Inhibition Using Weekly Erlotinib for Recurrent Malignant Gliomas | January 7, 2011 | December 31, 2018 |
| NCT01392209 | Completed | Phase 1 | Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma | July 8, 2011 | November 15, 2019 |
| NCT04114786 | Completed | N/A | 3D Printed Mask for GBM and Brain Mets | September 26, 2019 | October 18, 2022 |
| NCT01454596 | Completed | Phase 1/Phase 2 | CAR T Cell Receptor Immunotherapy Targeting EGFRvIII for Patients With Malignant Gliomas Expressing EGFRvIII | May 16, 2012 | January 17, 2019 |
| NCT01469247 | Completed | Phase 1/Phase 2 | Diffuse Intrinsic Pontine Glioma (DIPG) Reirradiation (ReRT) | December 7, 2011 | September 20, 2022 |
| NCT01478178 | Completed | Phase 1/Phase 2 | Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma | October 2011 | October 2016 |
| NCT01502917 | Completed | Phase 1 | Convection-Enhanced Delivery of 124I-Omburtamab for Patients With Non-Progressive Diffuse Pontine Gliomas Previously Treated With External Beam Radiation Therapy | December 2011 | January 2022 |
| NCT01534104 | Completed | N/A | MRI and Diffusion Imaging of Eloquent Brain Areas to Optimize Brain Tumor Resection Planning | February 2012 | June 8, 2023 |
| NCT01604512 | Completed | N/A | A Comparison of MRI Perfusion and FDG PET/CT to Distinguish Between Radiation Injury and Tumor Progression | May 2012 | December 29, 2023 |
| NCT04047602 | Completed | N/A | Radiosurgery Dose Reduction for Brain Metastases on Immunotherapy (RADREMI): A Prospective Pilot Study | December 12, 2019 | February 20, 2024 |
| NCT01650922 | Completed | Molecular Genetic Studies of Childhood Brain Tumors and Blood Samples | September 2005 | September 2008 | |
| NCT01654497 | Completed | Phase 1 | Dexanabinol in Patients With Brain Cancer | June 2012 | July 2017 |
| NCT01770626 | Completed | Early Phase 1 | A Pilot Study to Determine Nutrition Status in Glioblastoma Multiforme Patients | April 2011 | June 2014 |
| NCT00001574 | Completed | A Pilot Study of 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Pediatric Patients With Primary and Metastatic Brain Tumors | March 14, 1997 | May 6, 2019 | |
| NCT01854554 | Completed | Phase 2 | Glioblastoma Multiforme (GBM) Proton vs. Intensity Modulated Radiotherapy (IMRT) | May 17, 2013 | October 13, 2021 |
| NCT01974804 | Completed | Assessment of Early Treatment Response by Diffusion and Perfusion MRI in Patients With Brain Metastasis | October 25, 2013 | December 28, 2022 | |
| NCT03925246 | Completed | Phase 2 | Efficacy of Nivolumab for Recurrent IDH Mutated High-Grade Gliomas | July 30, 2019 | August 18, 2021 |
| NCT02045368 | Completed | Phase 1 | Study of Insulin-like Growth Factor (IGF)-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing IGF-1R | January 28, 2014 | September 30, 2016 |
| NCT03910556 | Completed | Re-craniotomy and Complications After Elective Neurosurgery | January 2017 | February 2019 | |
| NCT02193347 | Completed | Phase 1 | IDH1 Peptide Vaccine for Recurrent Grade II Glioma | January 28, 2016 | February 3, 2020 |
| NCT02334722 | Completed | Phase 4 | 1 Week Versus 6 Weeks of Levetiracetam in Surgical Brain Tumor Patients | August 5, 2015 | October 7, 2020 |
| NCT02423525 | Completed | Phase 1 | Safety Study of Afatinib for Brain Cancer | December 2016 | August 2021 |
| NCT02452216 | Completed | Early Phase 1 | Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNS | June 10, 2015 | January 12, 2017 |
| NCT02457715 | Completed | Feasibility of a Consumer Based Accelerometer in Monitoring Outpatient Physical Activity: A Study in Patients With Cancer and Amyotrophic Lateral Sclerosis | July 2015 | October 2017 | |
| NCT02617589 | Completed | Phase 3 | An Investigational Immuno-therapy Study of Nivolumab Compared to Temozolomide, Each Given With Radiation Therapy, for Newly-diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer) | March 1, 2016 | March 4, 2022 |
| NCT00185848 | Completed | Phase 1 | Assessing the Suitability of an Imaging Probe for Use in Clinical Cell and Gene Therapy Trials in Cancer and Rheumatoid Arthritis | April 2005 | June 2013 |
| NCT03538587 | Completed | N/A | Feasibility and Preliminary Efficacy of a Mindfulness-based Intervention for Children and Young Adults With High Grade or High-Risk Cancer and Their Caregivers | January 29, 2019 | September 13, 2022 |
| NCT02708056 | Completed | Phase 4 | Sugammadex Given for the Reversal of Rocuronium Induced Neuromuscular Blockade Under Sevoflurane Anesthesia in Infants | January 2015 | February 2016 |
| NCT02911155 | Completed | Cancer and Other Disease Risks in U.S. Nuclear Medicine Technologists | September 21, 2016 | May 1, 2020 | |
| NCT03026699 | Completed | Refining and Testing the Electronic Social Network Assessment Program (eSNAP) | May 5, 2017 | October 17, 2017 | |
| NCT03072134 | Completed | Phase 1 | Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma | April 24, 2017 | July 1, 2021 |
| NCT03115398 | Completed | N/A | A Simple Walking Program to Enhance Concurrent Chemoradiotherapy Delivery | February 16, 2017 | March 3, 2021 |
| NCT03434262 | Completed | Phase 1 | SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors | March 5, 2018 | May 24, 2024 |
| NCT00329589 | Completed | Phase 1 | A Trial Using Velcade Plus Chemoradiation for Central Nervous System, Head and Neck, and Cervical Cancer Patients | September 2005 | June 2010 |
| NCT00342004 | Completed | A Prospective Cohort Study of Occupational Exposures and Cancer Risk Among Women | May 1, 1997 | July 28, 2020 | |
| NCT00342953 | Completed | Study of Health Effects of Cosmetic Breast Augmentation | January 10, 2003 | July 10, 2020 | |
| NCT00352820 | Completed | Experience of Brain Tumor Caregivers | April 2006 | December 2006 | |
| NCT00392119 | Completed | Phase 1 | MR Guided Laser Interstitial Thermal Therapy for the "Minimal Invasive" Treatment of Brain Metastasis and Primary Brain Tumors | October 2006 | December 2008 |
| NCT00460395 | Completed | Phase 3 | Surgery Versus Stereotactic Radiosurgery in the Treatment of Single Brain Metastasis: A Randomized Trial | January 1998 | December 2005 |
| NCT00504660 | Completed | Phase 2 | 6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients | September 2003 | August 2010 |
| NCT00505141 | Completed | Urban Environmental Exposures and Childhood Cancer | September 2004 | February 2006 | |
| NCT00548756 | Completed | Phase 3 | Randomized Trial Comparing Radiosurgery With vs Without Whole Brain Radiotherapy | January 2, 2001 | June 2, 2023 |
| NCT02852655 | Completed | Phase 1 | A Pilot Surgical Trial To Evaluate Early Immunologic Pharmacodynamic Parameters For The PD-1 Checkpoint Inhibitor, Pembrolizumab (MK-3475), In Patients With Surgically Accessible Recurrent/Progressive Glioblastoma | September 21, 2016 | June 2, 2022 |
| NCT00241670 | Completed | Phase 3 | Fluorescence-guided Resection of Malignant Gliomas With 5-Aminolevulinic Acid | October 1999 | |
| NCT02941536 | Completed | N/A | Correlation Between Circulating Tumor Cells and Brain Disease Control After Focal Radiotherapy for Metastases of Breast Cancer | November 1, 2016 | October 30, 2018 |
| NCT02743481 | Completed | Early Life Exposures in Agriculture | April 14, 2016 | April 15, 2020 | |
| NCT02798406 | Completed | Phase 2 | Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects | October 6, 2016 | June 30, 2021 |
| NCT00185861 | Completed | Phase 1 | Phase I Trial of Arsenic Trioxide and Stereotactic Radiotherapy for Recurrent Malignant Glioma | December 2003 | April 2009 |
| NCT02808416 | Completed | Phase 1 | Personalized Cellular Vaccine for Brain Metastases (PERCELLVAC3) | March 1, 2016 | June 30, 2019 |
| NCT02849171 | Completed | N/A | Assessing 11C-Choline (11C-CH) PET to Distinguish True Tumor Progression From Pseudoprogression in High-grade Gliomas | July 2016 | May 6, 2022 |
| NCT05116137 | Enrolling by invitation | N/A | The Impact of Resistance ExerciSe on Muscle Mass in GlioblaSToma Survivors | March 1, 2022 | December 31, 2025 |
| NCT04745156 | Not yet recruiting | N/A | A Study Using Brain Stimulation and Behavioral Therapy to Increase Extent of Resection in Low-Grade Gliomas | August 1, 2024 | September 2025 |
| NCT05184790 | Not yet recruiting | LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology | January 31, 2024 | January 31, 2026 | |
| NCT06322342 | Recruiting | Phase 2 | Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent | March 15, 2024 | March 2025 |
| NCT00870129 | Recruiting | N/A | Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors | March 2009 | September 2024 |
| NCT01849952 | Recruiting | Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas | February 28, 2020 | May 2024 | |
| NCT02691923 | Recruiting | Phase 2 | Diagnostic Performance of Fluorescein as an Intraoperative Brain Tumor Biomarker | March 2016 | December 2025 |
| NCT02800486 | Recruiting | Phase 2 | Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA | May 2016 | May 2026 |
| NCT02861898 | Recruiting | Phase 1/Phase 2 | Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma | June 2016 | December 2026 |
| NCT03152318 | Recruiting | Phase 1 | A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2 | July 18, 2017 | December 2025 |
| NCT03213002 | Recruiting | Phase 1/Phase 2 | Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM | June 13, 2017 | June 2026 |
| NCT03861299 | Recruiting | N/A | The SAFE-Trial: Awake Craniotomy Versus Surgery Under General Anesthesia for Glioblastoma Patients. | April 1, 2019 | September 1, 2027 |
| NCT04075305 | Recruiting | The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study | February 1, 2019 | May 1, 2025 | |
| NCT04367779 | Recruiting | Research of Biomarkers of Response to Proton Beam Therapy in Pediatric and Adult Patients. | September 24, 2020 | June 2024 | |
| NCT04478279 | Recruiting | Phase 1/Phase 2 | A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors | July 1, 2020 | December 2025 |
| NCT04689048 | Recruiting | Phase 1 | Assess Use of 18F-Fluciclovine for Patients With Large Brain Metastases Treated With Staged Stereotactic Radiosurgery | April 4, 2022 | December 2025 |
| NCT04755920 | Recruiting | Phase 2 | SGM-101 in Colorectal Brain Metastases. | January 1, 2024 | February 2026 |
| NCT04899908 | Recruiting | Phase 2 | Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases | September 15, 2021 | February 2026 |
| NCT04962672 | Recruiting | N/A | Anesthesia Induced Brain Cancer Survival (ABC Survival): A Feasibility Study | January 1, 2022 | June 30, 2025 |
| NCT05023434 | Recruiting | A Study to Measure the Effect of Brain Stimulation on Hand Strength and Function in Patients With Brain Tumors | September 8, 2021 | October 1, 2024 | |
| NCT05062772 | Recruiting | Brain Tumor Intraoperative Ultrasound Database | May 25, 2022 | December 30, 2023 | |
| NCT05106725 | Recruiting | Wearable Devices and Biomarkers Project (Healthiomics) | October 11, 2021 | December 31, 2025 | |
| NCT05179824 | Recruiting | Tempus Priority Study: A Pan-tumor Observational Study | October 19, 2020 | October 19, 2030 | |
| NCT05271240 | Recruiting | Phase 3 | Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM | April 27, 2022 | April 1, 2028 |
| NCT05366881 | Recruiting | cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease | May 3, 2022 | December 2026 | |
| NCT05427214 | Recruiting | N/A | Imaging Study on Halcyon 4.0 System for Patients Receiving Radiation Therapy | August 19, 2022 | October 2, 2024 |
| NCT05549414 | Recruiting | N/A | Pivotal Study of Proton Radiotherapy Treatments Using Fixed Beam Chair-Based Delivery System | March 30, 2023 | February 2026 |
| NCT05554302 | Recruiting | Phase 2 | Characterization of 18F-Fluciclovine PET Amino Acid Radiotracer in Resected Brain Metastasis | January 10, 2023 | June 30, 2025 |
| NCT05686798 | Recruiting | Phase 1 | Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma. | November 29, 2022 | October 2024 |
| NCT05858359 | Recruiting | N/A | Contextualized Neuropsychological Rehabilitation for CNS Cancer Survivors: The ImPACT Program | June 1, 2023 | June 1, 2026 |
| NCT05943262 | Recruiting | N/A | Record Voxel Rate Nonlinear Optical Microscope to Unravel Brain Connectome and Signaling | May 1, 2023 | December 31, 2026 |
| NCT05947149 | Recruiting | HRQoL in Patients With Solid Tumors Treated With Hadrontherapy | March 27, 2023 | March 26, 2025 | |
| NCT05954858 | Recruiting | N/A | Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma | June 29, 2023 | June 30, 2026 |
| NCT05961111 | Recruiting | Early Phase 1 | A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors | June 24, 2023 | June 2026 |
| NCT05979064 | Recruiting | N/A | Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM) | April 4, 2023 | April 2027 |
| NCT06048094 | Recruiting | Phase 1 | 18F-Fluciclovine PET Amino Acid Evaluation of Brain Metastasis Treated With Stereotactic Radiosurgery | April 11, 2024 | May 2027 |
| NCT06058988 | Recruiting | Phase 2 | Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer | September 22, 2023 | September 22, 2027 |
| NCT06180460 | Recruiting | N/A | CALM: Managing Distress in Malignant Brain Cancer | November 10, 2023 | July 31, 2025 |
| NCT05554159 | Suspended | N/A | A Virtually Delivered Exercise Intervention To Mitigate Cognitive Deficits From Radiotherapy In AYAs With Brain Tumors | June 5, 2023 | February 28, 2027 |
| NCT04222309 | Suspended | Phase 1 | Laparoscopically Harvested Omental Free Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Recurrent Glioblastoma Multiforme (rGBM) | January 6, 2020 | January 31, 2025 |
| NCT05169944 | Suspended | Phase 1 | Magrolimab in Children and Adults With Recurrent or Progressive Malignant Brain Tumors | April 22, 2022 | February 28, 2025 |
| NCT01105702 | Terminated | Phase 2 | Temodar (Temozolomide), Bevacizumab, Lithium and Radiation for High Grade Glioma | May 2010 | April 2015 |
| NCT03190967 | Terminated | Phase 1/Phase 2 | T-DM1 Alone Versus T-DM1 and Metronomic Temozolomide in Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases Following Stereotactic Radiosurgery | April 18, 2018 | June 13, 2023 |
| NCT03403361 | Terminated | N/A | Dual-Energy CT on Plan Quality, Dose-delivery Accuracy, and Simulated Outcomes of Patients Treated With Proton or Photon Therapy | June 1, 2018 | August 11, 2022 |
| NCT03149575 | Terminated | Phase 3 | VAL-083 Phase 3 Study in Temozolomide-Avastin (Bevacizumab) Recurrent GBM | October 27, 2017 | August 31, 2019 |
| NCT02768337 | Terminated | Phase 1/Phase 2 | Cambridge Brain Mets Trial 1 | March 10, 2015 | August 12, 2021 |
| NCT02692898 | Terminated | Biomarker Analysis of Central Nervous System Tumors | February 25, 2016 | November 15, 2019 | |
| NCT01113463 | Terminated | Phase 2 | TPI 287 in Patients With Recurrent Glioblastoma Multiforme | April 2010 | December 2012 |
| NCT01048060 | Terminated | Consent for Obtaining Additional Bone Marrow Specimens at Time of Diagnostic Bone Marrow Procedure | February 2002 | August 2016 | |
| NCT01014767 | Terminated | Phase 3 | Intercontinental Multidisciplinary Registry and Treatment Optimization Study for Choroid Plexus Tumors | November 2009 | January 2014 |
| NCT00636805 | Terminated | Phase 2 | Aloxi for Prevention of Chemotherapy Induced Nausea and Vomiting in Malignant Glioma Patients Receiving Irinotecan With Bevacizumab | May 2008 | January 2013 |
| NCT02047747 | Terminated | Phase 2 | A Phase II Study of Dacomitinib in Progressive Brain Metastases | February 2014 | February 2016 |
| NCT01987193 | Terminated | Feasibility Study of Tumor Blood Flow Measurement by Detection of Positron Activation Post Proton Therapy (DS01) | July 2012 | May 2018 | |
| NCT01902771 | Terminated | Phase 1 | Dendritic Cell Vaccine Therapy With In Situ Maturation in Pediatric Brain Tumors | September 3, 2013 | January 26, 2017 |
| NCT05590273 | Terminated | N/A | Forgotten Voices: Addressing Unmet Needs in Brain Tumor Caregivers | November 3, 2022 | March 28, 2023 |
| NCT01246869 | Terminated | Phase 1 | Assessment of Primary and Metastatic Brain Tumor Hypoxia With Fluoromisonidazole, FDG and Water | March 27, 2013 | May 3, 2014 |
| NCT01065805 | Terminated | Phase 1/Phase 2 | A Study to Demonstrate the Safety and Preliminary Efficacy of 18F-FLT in Patients With Solid Tumours or Lymphoma | March 20, 2009 | February 25, 2019 |
| NCT01205334 | Terminated | Phase 1/Phase 2 | Administration of CMV-Specific Cytotoxic T Cells in Patients With Glioblastoma Multiforme | November 2010 | March 2012 |
| NCT01058850 | Terminated | Phase 1 | Phase I Rindopepimut After Conventional Radiation in Children w/ Diffuse Intrinsic Pontine Gliomas | June 2011 | September 2013 |
| NCT01110876 | Terminated | Phase 1/Phase 2 | Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM) | June 2011 | July 2014 |
| NCT02370563 | Terminated | Phase 1 | PET Imaging of Intracranial Cancers With 18F-FSPG | November 2014 | March 2016 |
| NCT03593330 | Unknown status | N/A | Neurosurgical Transitional Care Programme | April 15, 2018 | April 15, 2020 |
| NCT03294486 | Unknown status | Phase 1/Phase 2 | Safety and Efficacy of the ONCOlytic VIRus Armed for Local Chemotherapy, TG6002/5-FC, in Recurrent Glioblastoma Patients | October 12, 2017 | September 2021 |
| NCT04501731 | Unknown status | Controlling Coordination After Childhood Cerebellar Cancer, a Pilot Study | April 28, 2022 | December 31, 2022 | |
| NCT00045968 | Unknown status | Phase 3 | Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer | December 2006 | |
| NCT01640509 | Unknown status | Phase 1/Phase 2 | Synchrotron Radiation to the Treatment of Intracranial Tumors | June 2012 | June 2019 |
| NCT01740570 | Withdrawn | Phase 1/Phase 2 | Phase I/II Cabazitaxel for Recurrent Malignant Glioma | April 2013 | |
| NCT03629964 | Withdrawn | N/A | Study to Develop Head Stabilizer for Use During Brain Radiation Therapy | July 16, 2018 | October 1, 2019 |
| NCT01445691 | Withdrawn | Phase 2 | More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery | November 2015 | September 2016 |
| NCT01320787 | Withdrawn | Phase 1 | 18-F-Fluoroacetate as PET Imaging Agent | October 2014 | |
| NCT04427228 | Withdrawn | Phase 2 | Single vs Multi-fraction SRS Patients on Immunotherapy | June 29, 2020 | December 12, 2022 |
- Exact Synonym (Disease Ontology)
- adult brain tumor
- Exact Synonym (Disease Ontology)
- adult malignant brain neoplasm
- Exact Synonym (Disease Ontology)
- brain neoplasm
- Exact Synonym (Disease Ontology)
- brain neoplasm, adult
- Exact Synonym (Disease Ontology)
- BT - Brain tumour
- Exact Synonym (Disease Ontology)
- malignant brain tumour
- Exact Synonym (Disease Ontology)
- malignant primary brain neoplasm
- Exact Synonym (Disease Ontology)
- malignant primary brain tumor
- Exact Synonym (Disease Ontology)
- malignant tumor of adult brain
- Exact Synonym (Disease Ontology)
- malignant tumor of Brain
- Exact Synonym (Disease Ontology)
- neoplasm of brain
- Exact Synonym (Disease Ontology)
- primary brain neoplasm
- Exact Synonym (Disease Ontology)
- primary brain tumor
- Exact Synonym (Disease Ontology)
- primary malignant neoplasm of brain
- Exact Synonym (Disease Ontology)
- tumor of the Brain
- Disase is a (Disease Ontology)
- DOID:3620
- Cross Reference ID (Disease Ontology)
- ICD10CM:C71
- Cross Reference ID (Disease Ontology)
- ICD9CM:191
- Cross Reference ID (Disease Ontology)
- ICD9CM:239.6
- Cross Reference ID (Disease Ontology)
- MESH:D001932
- Cross Reference ID (Disease Ontology)
- NCI:C170814
- Cross Reference ID (Disease Ontology)
- NCI:C2907
- Cross Reference ID (Disease Ontology)
- NCI:C3568
- Cross Reference ID (Disease Ontology)
- NCI:C5115
- Cross Reference ID (Disease Ontology)
- NCI:C7710
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:126952004
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:428061005
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:93727008
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0006118
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0153633
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0220624
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0750974
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0750979
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C1334557